World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00563251
Date of registration: 21/11/2007
Prospective Registration: No
Primary sponsor: Hospital Authority, Hong Kong
Public title: Effectiveness of Azithromycin Therapy in Improvement of Symptoms and Lung Function in Patients With Bronchiolitis Obliterans After Bone Marrow Transplantation
Scientific title: Azithromycin Therapy for Bronchiolitis Obliterans Syndrome After Allogenic Bone Marrow Transplantation
Date of first enrolment: April 2005
Target sample size: 30
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00563251
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment  
Phase:  N/A
Countries of recruitment
China
Contacts
Name:     Albert Lie, Dr
Address: 
Telephone:
Email:
Affiliation:  Department of Medicine, Queen Mary Hospital/ The University of Hong Kong
Key inclusion & exclusion criteria

Inclusion Criteria:

- Confirmed BOS post BMT

- Informed consent

Exclusion Criteria:

- Women currently pregnant or nursing

- Allergy to macrolide



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Bone Marrow Transplantation
Bronchiolitis Obliterans
Intervention(s)
Drug: Azithromycin
Drug: Placebo tablet
Primary Outcome(s)
Quality of life assessment by questionnaires [Time Frame: 3 months after treatment]
Spirometry [Time Frame: 3 months after treatment]
Secondary Outcome(s)
Secondary ID(s)
HARECCTR0500038
UW 04-165 T/487
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
The University of Hong Kong
Pfizer
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history